Drug Interactions between dasatinib and Vitamin B12
This report displays the potential drug interactions for the following 2 drugs:
- dasatinib
- Vitamin B12 (cyanocobalamin)
Interactions between your drugs
No interactions were found between dasatinib and Vitamin B12. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
dasatinib
A total of 777 drugs are known to interact with dasatinib.
- Dasatinib is in the drug class BCR-ABL tyrosine kinase inhibitors.
- Dasatinib is used to treat the following conditions:
Vitamin B12
A total of 15 drugs are known to interact with Vitamin B12.
- Vitamin b12 is in the drug class vitamins.
- Vitamin b12 is used to treat the following conditions:
Drug and food interactions
dasatinib food
Applies to: dasatinib
Do not consume grapefruit or grapefruit juice during treatment with dasatinib. Grapefruit juice can significantly increase the blood levels and effects of dasatinib, which may result in excessive slowing of heart rate or other conduction disturbances and it may affect your bone marrow function, resulting in low numbers of different types of blood cells. You may be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. Talk to your doctor if you have any questions or concerns. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, heart palpitations, paleness, fatigue, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscle aches, blood in phlegm, weight loss, pain or burning during urination, red or inflamed skin, or body sores during treatment with dasatinib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.